Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Effects of the STAMP-inhibitor asciminib on T cell activation and metabolic fitness compared to tyrosine kinase inhibition by imatinib, dasatinib, and nilotinib.
Cancer Immunol Immunother. 2023 Jun;72(6):1661-1672. doi: 10.1007/s00262-022-03361-8. Epub 2023 Jan 5.
Cancer Immunol Immunother. 2023.
PMID: 36602564
Free PMC article.
The small chain fatty acid butyrate antagonizes the TCR-stimulation-induced metabolic shift in murine epidermal gamma delta T cells.
Häselbarth L, Ouwens DM, Teichweyde N, Hochrath K, Merches K, Esser C.
Häselbarth L, et al.
EXCLI J. 2020 Mar 9;19:334-350. doi: 10.17179/excli2020-1123. eCollection 2020.
EXCLI J. 2020.
PMID: 32256272
Free PMC article.
Item in Clipboard
Synergistic lethality in chronic myeloid leukemia - targeting oxidative phosphorylation and unfolded protein response effectively complements tyrosine kinase inhibitor treatment.
Häselbarth L, Gamali S, Saul D, Krumbholz M, Böttcher-Loschinski R, Böttcher M, Zou D, Metzler M, Karow A, Mougiakakos D.
Häselbarth L, et al.
BMC Cancer. 2023 Nov 27;23(1):1153. doi: 10.1186/s12885-023-11623-6.
BMC Cancer. 2023.
PMID: 38012567
Free PMC article.
Item in Clipboard
Cite
Cite